Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Isotretinoin REMS Modifications Show How Advisory Panel Can Push FDA To Change Its Mind
Dec 14 2023
•
By
Sarah Karlin-Smith
Changes to isotretinoin REMS should make access to the acne drug easier. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Post-Marketing Regulation & Studies
More from Product Reviews